Drug Shortage Report for NALOXONE HYDROCHLORIDE INJECTION USP

Last updated on 2019-06-20 History
Report ID 65888
Drug Identification Number 02382482
Brand name NALOXONE HYDROCHLORIDE INJECTION USP
Common or Proper name NALOXONE HYDROCHLORIDE INJECTION
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) NALOXONE HYDROCHLORIDE
Strength(s) 0.4MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 1 ML
ATC code V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2018-10-30
Estimated end date 2019-06-21
Actual end date 2019-06-19
Shortage status Resolved
Updated date 2019-06-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2019-06-20 English Compare
v15 2019-06-19 French Compare
v14 2019-06-19 English Compare
v13 2019-06-05 French Compare
v12 2019-06-05 English Compare
v11 2019-05-03 French Compare
v10 2019-05-03 English Compare
v9 2019-01-31 French Compare
v8 2019-01-31 English Compare
v7 2019-01-07 French Compare
v6 2019-01-07 English Compare
v5 2018-12-12 French Compare
v4 2018-12-12 English Compare
v3 2018-10-31 English Compare
v2 2018-10-30 French Compare
v1 2018-10-30 English Compare

Showing 1 to 16 of 16